✦ LIBER ✦

Chemoembolization Decreases Drop-Off Risk of Hepatocellular Carcinoma Patients on the Liver Transplant List

✍ Scribed by Constantine Frangakis; Jean-Francois Geschwind; Daniel Kim; Yong Chen; Ayman Koteish; Kelvin Hong; Eleni Liapi; Christos S. Georgiades

Publisher: Springer
Year: 2010
Tongue: English
Weight: 322 KB
Volume: 34
Category: Article
ISSN: 1432-086X
DOI: 10.1007/s00270-010-0077-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drop-out rates of patients with hepatoce

Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization

✍ Yamini K. Maddala; Linda Stadheim; James C. Andrews; Lawrence J. Burgart; Charle 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

Patients with hepatocellular carcinoma (HCC) are assigned model for end stage liver disease (MELD) scores to provide access to liver transplantation (LT). An equitable policy would equate HCC progression beyond acceptable transplantation criteria with death on the waiting list. However, limited info

Transplantation for hepatocellular carci

Transplantation for hepatocellular carcinoma: Management of patients on the waiting list

✍ Pietro Majno; Gilles Mentha; Christian Toso; for the Geneva Liver Cancer Study G 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

In discussing the mananagement of patients in the waiting list, the terms neoadjuvant treatment, bridging, downstaging and dropout should be used consistently, and on the basis of accepted selection criteria (currently MC, incorporated into the tumor-nodemetastasis [TNM] staging system as follows: T

Tools for monitoring patients with hepat

Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation

✍ Norman Kneteman; Tito Livraghi; David Madoff; Eduardo de Santibañez; Michael Kew 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

For patients who are initially being listed for liver transplantation and for patients who are seeking to retain their active status on the wait list, the first step in the diagnostic consideration of hepatocellular carcinoma (HCC) is the accurate identification and staging of the tumors. Advances i

Outcome of patients with hepatocellular

Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system

✍ Michael Adler; Filip De Pauw; Pierre Vereerstraeten; Agnese Fancello; Jan Lerut; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation, the rules governing priority and access to the waiting list are not well defined. Patient-and tumor-related variables were evaluated in 226 patients listed primarily for HCC in Belgium, a region whe

Management of hepatocellular carcinoma o

Management of hepatocellular carcinoma on the waiting list before liver transplantation: Time for controlled trials?

✍ Pietro Majno; Emiliano Giostra; Gilles Mentha 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Francisco; RFTA, radiofrequency thermal ablation; TACE, transarterial chemoembolization; UNOS, United Network for Organ Sharing. This article is based on a review of the treatment of hepatocellular carcinoma while patients are on a liver transplant waiting list that our group published in Journal of

Preoperative Chemoembolization in Patien

Preoperative Chemoembolization in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation: Influence of Emergent Versus Elective Procedures on Patient Survival and Tumor Recurrence Rate

✍ A. H. Stockland; E. M. Walser; R. Paz-Fumagalli; J. M. McKinney; G. R. May 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 168 KB